tradingkey.logo
tradingkey.logo
Search

Xenon Pharmaceuticals Inc

XENE
Add to Watchlist
42.280USD
-15.070-26.28%
Market hours 09/18, 09:39ET
4.09BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-26.28%

5 Days

-28.10%

1 Month

-32.20%

6 Months

-23.41%

Year to Date

-5.67%

1 Year

+15.20%

Key Figures

42.970Open
44.700High
236.04KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.24%Turnover Ratio
57.350Prev. Close
42.000Low
10.15MTurnover
LossP/E Static
3.29P/B
0.00%Div Yield TTM
-35.98%ROA
72.66052wk High
12.73Volume Ratio
-234.33MNet Profit
96.75MShares
-4.7092EPS TTM
0.63Beta
-37.53%ROE
35.97052wk Low
4.71%Amplitude
100.00%Gross Margin
4.09BMarket Cap
-2.68Reward/Risk
3.79%Risk Rate
More news coming soon, stay tuned...

Xenon Pharmaceuticals Inc's Score

0.05vs previous score
Forecast8.90
Financial Health6.43
Technical3.49
Valuation Dimensions8.61
Institutional Confidence10.00
Risk Assessment7.71

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
81.294Target Price
+44.45%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy99999998
Buy1111111111111212
Hold00000000
Sell00000000
Strong Sell00000000

Xenon Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.11/-1.14
Revenue / Forecast
0.00/1.25M

Xenon Pharmaceuticals Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolXENE
Number of employees316
CountryCanada

Ownership

ShareholdersProportion
Fidelity Management & Research Company LLC6.42%
Avoro Capital Advisors LLC5.61%
Wellington Management Company, LLP4.93%
Driehaus Capital Management, LLC4.70%
Shareholder TypesProportion
Investment Advisor/Hedge Fund40.19%
Investment Advisor31.01%
Hedge Fund16.08%
Sovereign Wealth Fund1.10%

FAQs

What is the current price of Xenon Pharmaceuticals Inc (XENE)?

The current price of Xenon Pharmaceuticals Inc (XENE) is 57.35.

What is the symbol of Xenon Pharmaceuticals Inc?

The ticker symbol of Xenon Pharmaceuticals Inc is XENE.

What is the 52-week high of Xenon Pharmaceuticals Inc?

The 52-week high of Xenon Pharmaceuticals Inc is 72.66.

What is the 52-week low of Xenon Pharmaceuticals Inc?

The 52-week low of Xenon Pharmaceuticals Inc is 35.97.

What is the market capitalization of Xenon Pharmaceuticals Inc?

The market capitalization of Xenon Pharmaceuticals Inc is 5.55B.

Is Xenon Pharmaceuticals Inc (XENE) currently rated as Buy, Hold, or Sell?

According to analysts, Xenon Pharmaceuticals Inc (XENE) has an overall rating of Buy, with a price target of 81.29.

What is the Earnings Per Share (EPS TTM) of Xenon Pharmaceuticals Inc (XENE)?

The Earnings Per Share (EPS TTM) of Xenon Pharmaceuticals Inc (XENE) is -4.71.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.